EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa

Agnes N Kiragga iD, Annet Onzia, Vivian Nakate, Irene Bagaya, Evelyn Natuha, Emmanuel Mande, Olivia Kataike, Rosalind Parkes-Ratanshi iD, Matthew M Hamill iD, Yukari C Manabe

PLOS ONE · 30.12.2024 · 19 (12) · e0315191

DOI: 10.1371/journal.pone.0315191 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 30.12.2024. Verfasst von Agnes N Kiragga und 9 weiteren Autor:innen. Beteiligte Einrichtung: Research Department, Infectious Diseases Institute, Makerere College of Health Sciences, Kampala, Uganda. Hauptthemen laut MEDLINE: Sexually Transmitted Diseases, Mass Screening, Point-of-Care Systems. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIBIB NIH HHS, National Institute of Biomedical Imaging and Bioengineering.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Sexually Transmitted Infections (STIs) rank in the top 5 disease categories for which adults in developing countries seek healthcare services. Community pharmacies offer clients convenience, proximity, extended opening hours, privacy, and efficiency, which could make them desirable locations for HIV and STI screening and treatment. We examined the feasibility of using point-of-care (POC) STI tests for screening HIV and other STIs at community pharmacies.

Methods

We conducted a prospective cohort study of persons seeking medication and other services at 18 purposively selected community pharmacies in Kampala, Uganda. Study participants comprised two broad categories: i) Symptomatic persons aged 18 years who presented with at least one STI sign or symptom and were purchasing treatment for themselves; ii) persons presenting with no STI symptom who had come to purchase any other medication, including family planning services such as emergency contraception. POC tests were used to test HIV, Chlamydia trachomatis (Ct) , Neisseria gonorrhoeae (Ng) , Trichomonas vaginalis (Tv) , and Syphilis. Test results were returned on-site or via telephone within 48 to 72 hours. Descriptive statistics were used to estimate the prevalence of STIs.

Results

Of the 450 participants enrolled, 235 (52.2%) were symptomatic, 215 (47.8%) were asymptomatic, and 280 (62.2%) were females. STI testing was feasible, with an acceptability rate of 99.8%. 135 (30%) of participants had at least one STI; HIV prevalence was 39 (8.7%), Syphilis prevalence was 14 (3.1%), 50 (11.1%) tested positive for Ng, 39 (8.7%) were positive for Ct while. The prevalence of Tv was 25 (8.9%) (tested among women). A total of 107 (23.8%) participants had used an antibiotic in the preceding month.

Conclusion

Our research underscores the potentially pivotal role of community pharmacies in deploying POC diagnostics for STIs and antimicrobial stewardship by decreasing unnecessary antibiotic dispensation across Africa.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Sexually Transmitted DiseasesMass ScreeningPoint-of-Care SystemsHumansFemaleAdultMaleUgandaProspective StudiesPharmaciesYoung AdultPoint-of-Care TestingAdolescentMiddle AgedHIV InfectionsSyphilisChlamydia Infections

Autor:innen und Institutionen

  • Research Department, Infectious Diseases Institute, Makerere College of Health Sciences, Kampala, Uganda.
  • African Population and Health Research Center, Nairobi, Kenya.
  • Academy for Health Innovation, Kampala, Uganda.
  • Division of Infectious Diseases, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

ORCID-Profile: Agnes N Kiragga, Rosalind Parkes-Ratanshi, Matthew M Hamill

Förderung

  • NIBIB NIH HHS
  • National Institute of Biomedical Imaging and Bioengineering

Zitieren

APA

Kiragga, A. N., Onzia, A., Nakate, V., Bagaya, I., Natuha, E., Mande, E., Kataike, O., Parkes-Ratanshi, R., Hamill, M. M., & Manabe, Y. C. (2024). Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa. PLOS ONE, 19(12), e0315191. https://doi.org/10.1371/journal.pone.0315191

Vancouver

Kiragga AN, Onzia A, Nakate V, Bagaya I, Natuha E, Mande E, et al. Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa. PLOS ONE. 2024;19(12):e0315191. doi:10.1371/journal.pone.0315191

BibTeX
@article{Kiragga2024,
  author = {Kiragga, Agnes N and Onzia, Annet and Nakate, Vivian and Bagaya, Irene and Natuha, Evelyn and Mande, Emmanuel and Kataike, Olivia and Parkes-Ratanshi, Rosalind and Hamill, Matthew M and Manabe, Yukari C},
  title = {Community pharmacies: Key players in point-of-care diagnostics for STI screening in Africa},
  journal = {PLOS ONE},
  year = {2024},
  volume = {19},
  number = {12},
  pages = {e0315191},
  doi = {10.1371/journal.pone.0315191}
}
Kostenlos starten →